Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

Annals of Clinical Microbiology and Antimicrobials

Hakan Leblebicioglu¹  Ranjit Sah²  Ruchi Tiwari³  Bhoj Raj Singh⁴  Mamta Pathak⁵  Shailesh Kumar Patel⁵  Kuldeep Dhama⁵  Khan Sharun⁶  Alfonso J. Rodriguez-Morales⁷  D. Katterine Bonilla-Aldana⁸ 

[1] Department of Infectious Diseases, Samsun Liv Hospital;Department of Microbiology, Institute of Medicine, Tribhuvan University Teaching Hospital;Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU);Division of Epidemiology, ICAR-Indian Veterinary Research Institute;Division of Pathology, ICAR-Indian Veterinary Research Institute;Division of Surgery, ICAR-Indian Veterinary Research Institute;Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira;Semillero de Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las Américas;

关键词: COVID-19;    2019-nCoV;    SARS-CoV-2;    Coronavirus;    Therapeutics;    Ivermectin;   

DOI  :  10.1186/s12941-020-00368-w

来源: DOAJ

【 授权许可】

Unknown